About the Authors
- Wenjia Wang
-
* E-mail: wenjia.wang@pharnext.com
Affiliations Inserm U1219, Université de Bordeaux, Bordeaux, Aquitaine, France, Pharnext, Issy-Les-Moulineaux, France
- Mickaël Guedj
-
Affiliation Pharnext, Issy-Les-Moulineaux, France
- Viviane Bertrand
-
Affiliation Pharnext, Issy-Les-Moulineaux, France
- Julie Foucquier
-
Affiliation Pharnext, Issy-Les-Moulineaux, France
- Elisabeth Jouve
-
Affiliation CIC-CPCET, Service de Pharmacologie Clinique et Pharmacovigilance, AP-HM, Aix Marseille Université, Marseille, France
- Daniel Commenges
-
Affiliation Inserm U1219, Université de Bordeaux, Bordeaux, Aquitaine, France
- Cécile Proust-Lima
-
Affiliation Inserm U1219, Université de Bordeaux, Bordeaux, Aquitaine, France
- Niall P. Murphy
-
Affiliation Pharnext, Issy-Les-Moulineaux, France
- Olivier Blin
-
Affiliation CIC-CPCET, Service de Pharmacologie Clinique et Pharmacovigilance, AP-HM, Aix Marseille Université, Marseille, France
- Laurent Magy
-
Affiliation Centre de Référence Neuropathies Périphérique Rares, CHU de Limoges - Hôpital Dupuytren, Limoges, France
- Daniel Cohen
-
Affiliation Pharnext, Issy-Les-Moulineaux, France
- Shahram Attarian
-
Affiliation Aix Marseille Université, INSERM, GMGF, Marseille, France
Competing Interests
WW, MG, VB, JF, NPM and DCoh are employees of Pharnext. MG, VB, JF, NPM and DCoh have shares in the company. MG, VB and DCoh hold patent applications by Pharnext. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: WW MG. Data curation: VB JF SA EJ LM DCOh. Formal analysis: WW MG. Writing – original draft: WW MG. Writing – review & editing: JF NPM CP OB DCom.